The number of 139 patients diagnosed with malignant astrocytoma included in the study appears to be rather limited, considering that only 13 patients diagnosed with an AA IDH-mut, 10 patients diagnosed with an AA IDH-wt and 6 patients diagnosed with a GBM IDH-mut are covered. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).